The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the safety and tolerability of the Exportin 1 (XPO1) inhibitor Selinexor (SXR) in Asian patients (pts) with advanced solid cancers.
 
David Shao Peng Tan
Honoraria - Roche Pharma AG
Research Funding - Karyopharm Therapeutics (Inst)
 
Mei-Yan Pang
No Relationships to Disclose
 
Wei Peng Yong
Honoraria - Bayer; Lilly; Merck
Consulting or Advisory Role - Roche Pharma AG
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Ross A. Soo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer; Roche Pharma AG
Research Funding - Merck Serono (Inst)
 
Cheng Ean Chee
No Relationships to Disclose
 
Yee Liang Thian
No Relationships to Disclose
 
Anil Gopinathan
No Relationships to Disclose
 
Andrea Li Ann Wong
Research Funding - Otsuka
Travel, Accommodations, Expenses - Eisai
 
Priscillia Koe
No Relationships to Disclose
 
Raghav Sundar
Travel, Accommodations, Expenses - Roche Pharma AG
 
Jingshan Ho
No Relationships to Disclose
 
Sharon Friedlander
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Yosef Landesman
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Tami Rashal
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Dilara McCauley
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Sharon Shacham
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Soo Chin Lee
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Roche Pharma AG
 
Boon C. Goh
Consulting or Advisory Role - Bayer; Otsuka
Research Funding - Bayer